News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Little Green Pharma.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: TGA’s new ruling has cannabis stocks rushing toward psychedelics – LGP is one of them
News
Rise and Shine: Everything you need to know before the ASX opens
News
CLOSING BELL: Not even the promise of top-shelf psychedelics could lift the market’s mood
News
ASX Small Caps Lunch Wrap: Who’s riding high on some psychedelic news this morning?
Health & Biotech
Australia just became the first country to recognise psychedelics as medicine. These are the ASX stocks you need to know about
Health & Biotech
Weed Week: Codeine demand drops when recreational cannabis is legal, study finds
News
ASX Earnings Wrap: Tyro rallies 7pc as revenue surges; Baby Bunting crashes 10pc on earnings flop
Health & Biotech
There’s some very good resins why our Little Green Pharma is already leading the 2023 German invasion
Health & Biotech
Weed Week: Aussie companies jostle to become the world’s supplier of medicinal cannabis
Health & Biotech
ASX Health Stocks: Little Green Pharma closing in on first over-the-counter CBD product in Australia
Health & Biotech
ASX Health Stocks: Little Green Pharma ships new cannabis flowers from Denmark to Australia
Health & Biotech
Weed Week: Oregon pardons cannabis convictions and bulk people light up on Turkey Day
Health & Biotech
ASX Health Stocks: Zelira to test its own drug against a Big Pharma’s multi-billion dollar revenue star
Health & Biotech
Weed Week: More US states vote to legalise cannabis and Czech Republic to follow in Germany’s footsteps
Health & Biotech
ASX Biotech Stocks: HitIQ nabs landmark deal with Premier League for its concussion management tech
News
ASX Quarterlies: Nuheara rockets 33pc, Dicker continues to grow, while these biotechs are all cashed up
Explainers